key: cord-0787881-bx0s3eqa authors: Quesada, J.A.; López-Pineda, A.; Gil-Guillén, V.F.; Arriero-Marín, J.M.; Gutiérrez, F.; Carratala-Munuera, C. title: Incubation period of COVID-19: A systematic review and meta-analysis() date: 2020-11-28 journal: Rev Clin Esp (Barc) DOI: 10.1016/j.rceng.2020.08.002 sha: 7f3d3761994ca17e835cb18bd4d547f68e7de2eb doc_id: 787881 cord_uid: bx0s3eqa BACKGROUND AND OBJECTIVE: The incubation period of COVID-19 helps to determine the optimal duration of the quarantine and inform predictive models of incidence curves. Several emerging studies have produced varying results; this systematic review aims to provide a more accurate estimate of the incubation period of COVID-19. METHODS: For this systematic review, a literature search was conducted using Pubmed, Scopus/EMBASE, and the Cochrane Library databases, covering all observational and experimental studies reporting the incubation period and published from 1 January 2020 to 21 March 2020.We estimated the mean and 95th percentile of the incubation period using meta-analysis, taking into account between-study heterogeneity, and the analysis with moderator variables. RESULTS: We included seven studies (n = 792) in the meta-analysis. The heterogeneity (I(2) 83.0%, p < 0.001) was significantly decreased when we included the study quality and the statistical model used as moderator variables (I(2) 15%). The mean incubation period ranged from 5.6 (95% CI: 5.2 to 6.0) to 6.7 days (95% CI: 6.0 to 7.4) according to the statistical model. The 95(th) percentile was 12.5 days when the mean age of patients was 60 years, increasing 1 day for every 10 years. CONCLUSION: Based on the published data reporting the incubation period of COVID-19, the mean time between exposure and onset of clinical symptoms depended on the statistical model used, and the 95th percentile depended on the mean age of the patients. It is advisable to record sex and age when collecting data in order to analyze possible differential patterns. Resultados. Se incluyeron siete estudios (N = 792) en el metaanálisis. La heterogeneidad (I 2 83,0 %, p <0,001) disminuyó significativamente cuando se tuvo en cuenta la calidad del estudio y el modelo estadístico utilizado como variables moderadoras (I 2 15%). El período medio de incubación oscilaba entre 5,6 (IC 95 %: 5,2 a 6,0) y 6,7 días (IC 95 %: 6,0 a 7,4) según el modelo estadístico utilizado. El percentil 95 fue de 12,5 días cuando la edad media de los pacientes era de 60 años, aumentando 1 día por cada 10 años de edad. Conclusión. Según los datos publicados sobre el período de incubación de la COVID-19, el tiempo medio entre la exposición y la aparición de los síntomas clínicos depende del modelo estadístico utilizado y el percentil 95, de la edad media de los pacientes. Se recomienda registrar el sexo y la edad en la recogida de los datos para poder analizar los posibles patrones diferenciales. Province of China, in December 2019. 1 Disease presentation ranges from no symptoms (asymptomatic in rare cases) to severe pneumonia and death. 2 The virus's impact has been farranging and devastating to health and economic systems around the globe. As of 27 March 2020, a total of 509,164 confirmed cases had been reported worldwide. 3 In response to its is highly contagious nature and rapid, person-to-person transmission, the World Health Organization (WHO) officially declared the COVID-19 outbreak a pandemic on 11 March 2020. 3 J o u r n a l P r e -p r o o f Possible vaccines and specific antiviral medicines are currently being investigated, 4 but pending these developments, the most effective measures to prevent and control the outbreak are frequent handwashing, social distancing, and respiratory hygiene, among others. 5 However, because of the fast spread of infections, health authorities in places like China, Italy, and Spain have declared a quarantine period for all affected populations. 6 Quantifying the length of the incubation period for COVID-19, that is, the time between exposure to the virus and onset of clinical symptoms is a key research question because this information can inform public health control measures for infectious diseases, including the appropriate duration of the quarantine period. 7 Recent studies have reported varying estimates. One based on 10 confirmed cases in China reported a mean incubation period of 5.2 days (95% confidence interval [CI] 4.1 to 7.0) and a 95th percentile (95%tile) of the distribution of 12.5 days (95% CI 9.2 to 18.0). 8 The mean incubation period in 88 travellers from Wuhan was 6.5 days (95% CI 5.6 to 7.9), while the 95%tile was 11.3 days (95% CI: 9.1 to 15.7). 9 Lauer et al. 10 analysed publicly available data for 181 confirmed cases from China, estimating a median incubation period of 5.1 days (95% CI 4.5 to 5.8) and a 97.5 th percentile of the distribution of 11.5 days (95% CI 8.2 to 15.6). The 95%tile of the incubation period may indicate how many days it is necessary to extend the quarantine period to ensure the absence of disease among healthy exposed individuals. Several of these early reports consider the incubation period a symmetric variable and estimate the mean through the midpoint; however, this leads to an overestimation of the incubation period distribution. 11 The incubation period can be estimated by parametric distributions such as Gamma, Weibull, or LogNormal distributions. 12 For the time being, the WHO assumes that the incubation period for COVID-19 ranges from 1 to 14 days 4 , and the European Centre for Disease Prevention and Control (ECDC) considers 5.1 J o u r n a l P r e -p r o o f days as a mean period. 13 We carried out a systematic review of published research studies with the aim of providing a more accurate estimate of the incubation period of COVID-19. This systematic review and meta-analysis were conducted according to the Preferred Reporting We included observational and experimental studies reporting the incubation period of COVID-19. Eligible studies had to report the mean incubation period of COVID-19. Studies that duplicated other publications, reviews, editorials, or letters were excluded. During the selection process, two review authors independently assessed all papers yielded by the search strategy. After screening titles and abstracts to eliminate unrelated studies, we retrieved the full text of all remaining records and checked them against the eligibility criteria. We resolved disagreements through discussion and consulted a third review author if necessary. The following information was collected from each study: first author, publication date, data origin, sample size, mean age and range, percentage of men in the sample, the statistical model used, mean incubation period with its 95% CI, standard deviation (SD) and interquartile range (IQR), and mean 95%tile and its 95% CI. Since COVID-19 was first identified in December 2019 and given the current pandemic sweeping the world, there are no experimental studies on the incubation period, yet and many of the existing research studies aimed to provide information on the process of the outbreak. Thus, the quality of the overall study was not assessed, but rather a quality assessment of reported data was performed using an adapted version of the criteria used by Awofisayo-Okuyelu et al. 15 . The individual studies included in the present meta-analysis were scored according to the following checklist: The maximum quality score was 4 points. The studies were categorized in low (1 or 2 points) or high quality (3 or 4 points) according to the score, and those studies whose score was 1 point were excluded from the meta-analysis. We meta-analysed data for the mean and 95%tile of the incubation period, applying a randomeffects model and evaluating between-study variance using the Tau 2 and heterogeneity using Dixon's Q test and Higgin's I 2 statistic. 16 Where no SDs were available, these were estimated using 95% CIs after obtaining the logs, according to the formula: Where T(0.975,n-1) is the value of the student's t distribution, with a tail probability of 97.5% and n -1 degree of freedom. 17 The original scale was restored using the exponential function. Heterogeneity was assessed using an analysis of the following moderator variables: date of publication, distributional model, mean age, age range, percentage of men, and study quality. The search yielded 40 unique records. After screening titles and abstracts, the full texts of 27 papers were examined: 13 were excluded because they did not report the mean incubation period or were literature reviews. We finally included 14 studies in the review 6,8-10,18-27 : only 7 of them 8-10,18-21 were amenable to meta-analysis since the rest provided neither the 95% CI nor the SD of the incubation period ( fig. 1 fig. 1 ) or some of the moderator variables were missing. Only 6 of them were included in the meta-analysis of the 95%tile of the incubation period distribution. Table 1 Table 1 shows the characteristics of the included studies. Linton et al. 18 determined the incubation period in two different samples, so we included their results in the meta-analysis as if they came from two separate studies. The first study was published on 29 January 2020 and the last on 18 March 2020. All of the data collected came from the Chinese provinces affected by COVID-19, except for those reported by Backer et al., 9 who analysed travellers from Wuhan, and the study by Ki et al., 23 performed in South Korea. The study by Li et al. 8 obtained the best quality score (4 points), and the study by Leung 6 obtained the worst score (1 point) and was excluded from the metaanalysis. The mean age of the infected people ranged from 35 to 59 years, with a higher incidence in men than in women in most studies. Of the studies presenting data for the SD or the 95% CI, the shortest mean incubation period reported was 4.9 days (Jiang et al.) 19 , while the longest was 7.2 days (Leung) 6 . The 95%tile for the incubation period ranged from 10.6 days to 14.6 days. Altogether, the total sample size for the meta-analysis of the mean incubation period was 792 ( fig. 2 fig 2: on the left side). The pooled estimate of the mean incubation period was 5.6 days (95% CI 5.1 to 6.1). The lowest value reported by any included study was 5.0 days (Linton et al. 18 and Song et al. 21 ) and the highest 6.7 days (Tian et al. 20 ). There was considerable betweenstudy heterogeneity (I 2 83.0%, p < 0.001). Moderator variables were analysed to identify and eliminate the observed heterogeneity (Table The right side of fig. 2 fig. 2 shows the global estimate of the mean incubation period according to the study quality, and statistical model used. Low-quality studies provided lower estimates of the mean incubation period ranging from 4.9 to 6.0 days. High-quality studies provided estimates of 5.6, 6.1 and 6.7 days, according to LogNormal, Gamma, and Unknown model, respectively. A total of 489 people contributed data to the analysis of the 95%tile of the incubation period distribution ( fig. 3 fig. 3 : on the left side). The pooled estimate showed 11.2 days (95% CI 10.7 to 11.8). The lowest, estimate of 10.6 days, was reported by Linton et al., 18 and the highest, of 12.5 days, by Li et al. 8 There was considerable heterogeneity (I2 61.7%, p = 0.02). An analysis of moderator variables was also performed including the mean age into the model and the observed heterogeneity was removed, going from 61.7% to 0.0% (Table 3 Table 3 ). The global 95%tile of the incubation period varied according to the age of the patients: 10.5, 11.5 and 12.5 days for 40, 50 and 60 years old, respectively. Thus, the 95%tile increased 1 day when age increased 10 years ( fig. 3 fig. 3 : on the right side). Our results show that the mean incubation period for COVID-19 is 5.6 days (95% CI 5.1 to 6.1) and may vary depending on the model used for its estimation and the study quality. The 95%tile of its distribution is about 11.2 days (10.7 to 11.8), and it varies according to the mean age of the patients, increasing 1 day per every 10 years. The WHO is operating under the assumption that the incubation period is from 1 to 14 days, 4 while the ECDC 13 considered all data published to date, resulting in an estimate of 5.6 days, or 9.8% longer than the estimate being used by European authorities. Although the magnitude of the difference is not large, it could affect the predictive modelling of the incidence curves that different teams of epidemiological researchers are constructing. 28, 29 Recent reports have suggested that both the incidence and severity of COVID-19 infections differ according to sex, especially between age groups. 10, 20, 23 These findings also raise the possibility that the distribution of the incubation period could also depend to some extent on sex and age. We were unable to evaluate this possibility in our review, as studies did not disaggregate their data according to patients' gender. Our review did find that the estimated mean incubation period can vary depending on the parametric model used and the study quality, as evident from the analysis of moderators ( Table 2 Table 2 ). This phenomenon should be interpreted with caution, as there could be unmeasured sociodemographic and clinic variables or heterogeneity in the quality of data sources that could explain these differences. however, we have included all published studies that met eligibility criteria because we considered this bias is not applicable to these types of descriptive studies with no group comparison. Another limitation of the present meta-analysis was that data came from patients with symptoms. However, Mizumoto et al. 31 estimated that 17.9% of cases are asymptomatic, and thus, our findings cannot be extrapolated to this population. The mean time from exposure to COVID-19 and the appearance of the first symptoms ranged from 5.6 to 6.7 days according to the statistical model used, including high-quality studies. The 95%tile of the incubation period varied according to the mean age of patients, increasing 1 day when the mean age increased 10 years. Both the predictive models of incidence curves and the prescribed quarantine periods should take these figures into account. It is advisable to collect data on age and sex when calculating the incubation period in order to analyse potential differences in epidemiological patterns based on these variables. J o u r n a l P r e -p r o o f A pneumonia outbreak associated with a new coronavirus of probable bat origin WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 Available at COVID-19) outbreak situation WHO. Q&A on coronaviruses (COVID-19) Basic protective measures against the new coronavirus The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: The need of a longer quarantine period Incubation period of typhoidal salmonellosis: a systematic review and meta-analysis of outbreaks and experimental studies occurring over the last century of Novel Coronavirus-Infected Pneumonia Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application The distribution of incubation periods of infectious disease Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia European Centre for Disease Prevention and Control. Considerations relating to social distancing measures in response to COVID-19 -second update Preferred reporting items for systematic review and meta-analysis protocols A systematic review and meta-analysis on the incubation period of Campylobacteriosis Conducting meta-analyses in R with the metafor package Cochrane Handbook for Systematic Reviews of Interventions 6 Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data Does SARS-CoV-2 has a longer incubation period than SARS and MERS? Characteristics of COVID-19 infection in Beijing Study on assessing early epidemiological parameters of COVID-19 epidemic in China Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang Clinical Characteristics of Coronavirus Disease 2019 in China Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin. Zhonghua Liu Xing Bing XueZaZhi SARS incubation and quarantine times: when is an exposed individual known to be disease free Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare that they do not have any conflicts of interest. We thank Megan Harris for her comments that have greatly improved the manuscript.